The Ch1VPP regimen, a risk factor for herpes zoster virus infection in patients treated for Hodgkin's disease
- 1 July 1994
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 53 (1), 51-53
- https://doi.org/10.1111/j.1600-0609.1994.tb00180.x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Peripheral nervous system and spinal cord involvement in lymphomaActa Neurologica Scandinavica, 2009
- Herpes zoster in patients with rheumatoid arthritis treated with weekly, low-dose methotrexateAmerican Journal Of Medicine, 1991
- Varicella-zoster infection in adult cancer patients. A population studyArchives of Internal Medicine, 1988
- Herpes zoster and occult malignancyJournal of the American Academy of Dermatology, 1984
- Herpes zoster in patients with carcinoma of the lungAmerican Journal Of Medicine, 1982
- Five years' experience with Ch1VPP: Effective low-toxicity combination chemotherapy for Hodgkin's diseaseBritish Journal of Cancer, 1982
- Curability of Advanced Hodgkin's Disease with ChemotherapyAnnals of Internal Medicine, 1980
- Herpes zoster and impaired cell-associated immunity to the varicella-zoster virus in patients with Hodgkin's diseaseThe American Journal of Medicine, 1977
- Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPPCancer, 1975
- Varicella-zoster infection in Hodgkin's diseaseAmerican Journal Of Medicine, 1965